Literature DB >> 11347706

The effect of recombinant human bone morphogenetic protein-2 on femoral reconstruction with an intercalary allograft in a dog model.

G E Pluhar1, P A Manley, J P Heiner, R Vanderby, H J Seeherman, M D Markel.   

Abstract

This study compared the effect of augmentation of allograft host bone junctions with recombinant human bone morphogenetic protein-2 (rhBMP-2) on an absorbable collagen sponge (ACS), autogenous cancellous bone graft (CBG), and a collagen sponge alone in a canine intercalary femoral defect model repaired with a frozen allograft. Outcome assessment included serial radiographs, dual energy X-ray absorptiometry scans, and gait analyses, and mechanical testing and histology of post-mortem specimens. The distal junction healed more quickly and completely with rhBMP-2 than ACS alone based on qualitative radiography and histologic evaluations. The primary tissue in the unhealed gaps in the ACS group was fibrous connective tissue. The proximal allograft host bone junction had complete bone union in the three treatment groups. There was significantly greater new bone callus formation at both junctions with rhBMP-2 than with CBG or ACS alone that resulted in increased bone density around the allograft host bone junctions. All dogs shifted their weight from the treated leg to the contralateral pelvic limb immediately after surgery. Weight bearing forces were redistributed equally between the pelvic limbs at 12 weeks after surgery with rhBMP-2, at 16 weeks after surgery with CBG, and at 24 weeks after surgery with ACS alone. Bending and compressive stiffnesses of the whole treated femora were equal to the contralateral control femora in all treatment groups, whereas torsional rigidities of the whole treated femora for the CBG and ACS groups were significantly less than the control. Both the proximal and distal junctions the treated with rhBMP-2 had torsional stiffnesses and strengths equal to intact control bones. Ultimate failure torques of the proximal junctions of the CBG group and of both junctions of the ACS group were significantly less than the BMP-treated bones. Augmentation of the allograft host bone junctions with rhBMP-2 on an ACS gave results for all parameters measured that equaled or exceeded autogenous graft in this canine intercalary femoral defect model.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11347706     DOI: 10.1016/S0736-0266(00)90002-0

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  16 in total

1.  Osteogenic protein-1 delivered by hydroxyapatite-coated implants improves bone ingrowth in extracortical bone bridging.

Authors:  Neil Saran; Renwen Zhang; Robert E Turcotte
Journal:  Clin Orthop Relat Res       Date:  2010-09-28       Impact factor: 4.176

2.  Quantification of massive allograft healing with dynamic contrast enhanced-MRI and cone beam-CT: a pilot study.

Authors:  Nicole Ehrhart; Susan Kraft; David Conover; Randy N Rosier; Edward M Schwarz
Journal:  Clin Orthop Relat Res       Date:  2008-06-10       Impact factor: 4.176

3.  The effect of mesenchymal stem cells delivered via hydrogel-based tissue engineered periosteum on bone allograft healing.

Authors:  Michael D Hoffman; Chao Xie; Xinping Zhang; Danielle S W Benoit
Journal:  Biomaterials       Date:  2013-08-16       Impact factor: 12.479

4.  Polyglutamate directed coupling of bioactive peptides for the delivery of osteoinductive signals on allograft bone.

Authors:  Bonnie K Culpepper; Paul P Bonvallet; Michael S Reddy; Selvarangan Ponnazhagan; Susan L Bellis
Journal:  Biomaterials       Date:  2012-11-23       Impact factor: 12.479

5.  Clinical application of recombinant human bone morphogenetic protein in cats and dogs: a review of 13 cases.

Authors:  Cory B Pinel; G Elizabeth Pluhar
Journal:  Can Vet J       Date:  2012-07       Impact factor: 1.008

6.  Spatiotemporal delivery of bone morphogenetic protein enhances functional repair of segmental bone defects.

Authors:  Yash M Kolambkar; Joel D Boerckel; Kenneth M Dupont; Mehmet Bajin; Nathaniel Huebsch; David J Mooney; Dietmar W Hutmacher; Robert E Guldberg
Journal:  Bone       Date:  2011-05-18       Impact factor: 4.398

Review 7.  Taking cues from the extracellular matrix to design bone-mimetic regenerative scaffolds.

Authors:  Andrew S Curry; Nicholas W Pensa; Abby M Barlow; Susan L Bellis
Journal:  Matrix Biol       Date:  2016-03-02       Impact factor: 11.583

8.  Gene therapy to enhance allograft incorporation after host tissue irradiation.

Authors:  Brandon G Santoni; A Simon Turner; Donna L Wheeler; Richard W Nicholas; Tom J Anchordoquy; Nicole Ehrhart
Journal:  Clin Orthop Relat Res       Date:  2008-05-28       Impact factor: 4.176

9.  Emerging ideas: Engineering the periosteum: revitalizing allografts by mimicking autograft healing.

Authors:  Michael D Hoffman; Danielle S W Benoit
Journal:  Clin Orthop Relat Res       Date:  2012-11-21       Impact factor: 4.176

10.  Recombinant human bone morphogenetic protein-2 in the treatment of bone fractures.

Authors:  Neil Ghodadra; Kern Singh
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.